Wealthfront Advisers LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1763921
Palo Alto, CA
Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,368,521
-$2,078,387 QoQ
Shares Held
7,006
-16.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#406
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthfront Advisers LLC holds $35,327,037 across 19 Biotechnology names. REGN ranks #2 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
41,608 | $20,667,941 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
7,006 | $4,368,521 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,554 | $2,876,040 | |
| 4 | INSM |
INSMED Inc
|
17,511 | $1,867,022 | |
| 5 | INCY |
Incyte Corp
|
9,753 | $1,105,600 | |
| 6 | MRNA |
Moderna, Inc.
|
15,621 | $1,093,938 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
39,822 | $587,772 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
8,602 | $469,153 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,368,521 | 7,006 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,446,908 | 8,344 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,284,565 | 8,142 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,339,883 | 5,940 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,422,875 | 4,615 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,916,370 | 6,175 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $5,234,200 | 7,348 | Shares | Sole | 2025-04-01 | |
| 2024-09-30 | $9,975,216 | 9,489 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,075,173 | 9,586 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,374,652 | 9,740 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $8,441,245 | 9,611 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,790,139 | 9,466 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $7,648,858 | 10,645 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $13,629,861 | 16,588 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $7,427,018 | 10,294 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $7,142,893 | 10,369 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,095,540 | 8,620 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,611,392 | 3,739 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,335,992 | 3,699 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,159,887 | 3,569 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,950,980 | 3,493 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,067,366 | 6,483 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,721,879 | 7,704 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,464,711 | 4,403 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,168,765 | 5,081 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $427,742 | 876 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||